GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Moberg Pharma AB (FRA:MB8) » Definitions » Forward Dividend Yield %

Moberg Pharma AB (FRA:MB8) Forward Dividend Yield % : 0.00% (As of May. 11, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Moberg Pharma AB Forward Dividend Yield %?

As of today (2025-05-11), the Forward Annual Dividend Yield of Moberg Pharma AB is 0.00%.

As of today (2025-05-11), the Trailing Annual Dividend Yield of Moberg Pharma AB is 0.00%.

FRA:MB8's Forward Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.9
* Ranked among companies with meaningful Forward Dividend Yield % only.

Moberg Pharma AB's Dividends per Share for the three months ended in Dec. 2024 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Moberg Pharma AB's Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Moberg Pharma AB's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Moberg Pharma AB's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Moberg Pharma AB's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Moberg Pharma AB's Forward Dividend Yield % falls into.


;
;

Moberg Pharma AB Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Moberg Pharma AB  (FRA:MB8) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Moberg Pharma AB Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Moberg Pharma AB's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Moberg Pharma AB Business Description

Traded in Other Exchanges
Address
Gustavslundsvagen 42, 5th Floor, Bromma, Stockholm, SWE, SE-167 51
Moberg Pharma AB is a Swedish pharmaceutical company focused on commercializing proprietary innovations based on drug delivery of compounds. The company develops and markets consumer healthcare products that relieve pain and treat skin conditions, mainly nail fungus. The Company's main product, MOB-015, is a novel topical treatment for onychomycosis It has a single operating segment, the development, and commercialization of medical products. Its geographic areas are Europe, the Americas, and Rest of the world.

Moberg Pharma AB Headlines

No Headlines